Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

Curr Rheumatol Rep

Boston University School of Medicine, 72 E. Concord St. 5th Floor Room 501, Boston, MA, 02118, USA.

Published: January 2016

AI Article Synopsis

  • The exact cause of systemic sclerosis is still unclear, but immune cells, particularly macrophages and monocytes, might play a key role in starting or maintaining the disease.
  • These immune cells are categorized into two types: the pro-inflammatory M1 phenotype and the pro-fibrotic/anti-inflammatory M2 phenotype.
  • This review focuses on significant research that explores how these macrophages and monocytes contribute to the development of systemic sclerosis.

Article Abstract

The pathogenesis of systemic sclerosis is still unknown, although immune cells, mainly macrophages/monocytes, may have an important role in initiating and/or perpetuating the disease. Macrophages and monocytes are often classified as pro-inflammatory M1 phenotype or classic activation and pro-fibrotic/anti-inflammatory M2 phenotype or alternative activation. In this review, we highlighted the most relevant research regarding the involvement of macrophages/monocytes in the pathogenesis of this complex disease.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-015-0554-8DOI Listing

Publication Analysis

Top Keywords

systemic sclerosis
8
macrophage involvement
4
involvement systemic
4
sclerosis evidence?
4
evidence? pathogenesis
4
pathogenesis systemic
4
sclerosis unknown
4
unknown immune
4
immune cells
4
cells macrophages/monocytes
4

Similar Publications

This study aimed to examine whether a reported SSc-associated SNP rs2841277 in the PLD4 gene identified in an Asian population was also associated with SSc in European American (EA). The EA cohort consisting of 1005 SSc patients and 961 healthy controls was examined in this study. TaqMan genotyping assays were performed to examine the SNP.

View Article and Find Full Text PDF

The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis.

Sci Rep

December 2024

Respiratory Medicine Unit, Department of Clinical Medicine and Surgery, Monaldi Hospital- AO dei Colli, Federico II University of Naples, Via L. Bianchi, 5, 80131, Naples, Italy.

Quantitative assessment of the extent of radiological alterations in interstitial lung diseases is a promising field of application that goes beyond the limitations of qualitative scoring. Analysis of density histograms, i.e.

View Article and Find Full Text PDF

Citric acid is more effective than sodium thiosulfate in chelating calcium in a dissolution model of calcinosis.

Sci Rep

December 2024

Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M13 9PT, UK.

Calcinosis cutis affects 20-40% of patients with systemic sclerosis. This study tests the hypothesis that calcium-chelating polycarboxylic acids can induce calcium dissolution without skin toxicity or irritancy. We compared citric acid (CA) and ethylenediaminetetraacetic acid (EDTA) to sodium thiosulfate (STS) for their ability to chelate calcium in vitro using a pharmaceutical dissolution model of calcinosis (hydroxyapatite (HAp) tablet), prior to evaluation of toxicity and irritancy in 2D in vitro skin models.

View Article and Find Full Text PDF

Genetic Association of Juvenile Idiopathic Arthritis With Adult Rheumatic Disease.

JAMA Netw Open

December 2024

Department of Cell Biology, The Province and Ministry Cosponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Key Laboratory of Medical Epigenetics, Tianjin Institute of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.

Importance: Patients with juvenile idiopathic arthritis (JIA) may develop adult rheumatic diseases later in life, and prolonged or recurrent disease activity is often associated with substantial disability; therefore, it is important to identify patients with JIA at high risk of developing adult rheumatic diseases and provide specialized attention and preventive care to them.

Objective: To elucidate the full extent of the genetic association of JIA with adult rheumatic diseases, to improve treatment strategies and patient outcomes for patients at high risk of developing long-term rheumatic diseases.

Design, Setting, And Participants: In this genetic association study of 4 disease genome-wide association study (GWAS) cohorts from 2013 to 2024 (JIA, rheumatoid arthritis [RA], systemic lupus erythematosus [SLE], and systemic sclerosis [SSc]), patients in the JIA cohort were recruited from the US, Australia, and Norway (with a UK cohort included in the meta-analyzed cohort), while patients in the other 3 cohorts were recruited from US and Western European countries.

View Article and Find Full Text PDF

Background: The innate immune response aims to prevent pathogens from entering the organism and/or to facilitate pathogen clearance. Innate immune cells, such as macrophages, mast cells (MCs), natural killer cells and neutrophils, bear pattern recognition receptors and are thus able to recognize common molecular patterns, such as pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs), the later occurring in the context of neuroinflammation. An inflammatory component in the pathology of otherwise "primary cerebrovascular and neurodegenerative" disease has recently been recognized and targeted as a means of therapeutic intervention.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!